(LPTX) Leap Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Leap Therapeutics | (LPTX) share price targets
Complete technical analysis of Leap Therapeutics (LPTX) by charts plus indicators, forecast predictions and share price targets for Leap Therapeutics (LPTX)
Leap Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-05-30 View latest technical analysis
10 day averaged volume of Leap Therapeutics is 226409
| Date | Daily Closing Price | Open | High | Low | Volume |
| 30 Thu May 2024 | 2.36 | 2.23 | 2.37 | 2.20 | 0.666 times |
| 29 Wed May 2024 | 2.16 | 2.20 | 2.31 | 2.15 | 1.244 times |
| 28 Tue May 2024 | 2.28 | 2.44 | 2.47 | 2.23 | 0.704 times |
| 23 Thu May 2024 | 2.47 | 2.45 | 2.50 | 2.31 | 0.999 times |
| 22 Wed May 2024 | 2.50 | 2.51 | 2.59 | 2.49 | 0.431 times |
| 21 Tue May 2024 | 2.51 | 2.59 | 2.70 | 2.49 | 1.444 times |
| 20 Mon May 2024 | 2.57 | 2.63 | 2.72 | 2.50 | 0.516 times |
| 17 Fri May 2024 | 2.63 | 2.77 | 2.77 | 2.57 | 1.659 times |
| 16 Thu May 2024 | 2.74 | 2.80 | 2.80 | 2.71 | 0.589 times |
| 15 Wed May 2024 | 2.80 | 2.80 | 2.92 | 2.74 | 1.319 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 2.4, but if it comes above 2.4, then a intra day buy could be more profitable.
If you take a sell trade below 2.4, then use 2.4 as stoploss and 2.1 as target. However if you take a buy trade in stock , then use 2.4 as stoploss and 2.76 as target.
Share price targets for Leap Therapeutics (LPTX)
| Target Type | Value |
| Downside Target | 2.13 |
| Downside Target | 2.21 |
| Downside Target | 2.31 |
| Upside Target | 2.42 |
| Upside Target | 2.47 |
| Upside Target | 2.57 |
| Upside Target | 2.72 |
| Upside Target | 2.78 |
| Upside Target | 3.00 |
| Upside Target | 3.29 |
| Upside Target | 3.35 |
| Upside Target | 3.40 |
| Upside Target | 3.71 |
| Upside Target | 4.39 |
| Upside Target | 5.00 |
Intraday share price targets for Leap Therapeutics (LPTX)
| Target Type | Value |
| Downside Intraday Target | 2.18 |
| Downside Intraday Target | 2.01 |
| Upside Intraday Target | 2.5 |
| Upside Intraday Target | 2.65 |
| Downside Intraday Target | 2.33 |
Weekly technical analysis of Leap Therapeutics (LPTX)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 30 Thu May 2024 | 2.36 | 2.44 | 2.47 | 2.15 | 0.771 times |
| 23 Thu May 2024 | 2.47 | 2.63 | 2.72 | 2.31 | 0.609 times |
| 17 Fri May 2024 | 2.63 | 2.76 | 3.00 | 2.57 | 1.434 times |
| 10 Fri May 2024 | 2.78 | 3.19 | 3.29 | 2.72 | 1.023 times |
| 03 Fri May 2024 | 3.19 | 3.26 | 3.40 | 3.01 | 0.696 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Leap Therapeutics (LPTX)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 30 Thu May 2024 | 2.36 | 3.14 | 3.35 | 2.15 | 0.367 times |
| 30 Tue Apr 2024 | 3.10 | 2.69 | 4.39 | 2.42 | 2.936 times |
| 28 Thu Mar 2024 | 2.66 | 2.84 | 3.00 | 2.13 | 0.877 times |
| 29 Thu Feb 2024 | 2.79 | 3.02 | 3.71 | 2.78 | 0.649 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Leap Therapeutics (LPTX)
Price action analysis of Leap Therapeutics ( (LPTX) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Leap Therapeutics ( (LPTX) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Leap Therapeutics ( (LPTX) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Leap Therapeutics ( (LPTX) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Leap Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Leap Therapeutics in short term and the sell signal is strong.
Leap Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Leap Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Leap Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.51 and Leap Therapeutics (LPTX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Leap Therapeutics (LPTX) stock. Volume based technical analysis of Leap Therapeutics (LPTX) stock is negative.
Leap Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Leap Therapeutics ( (LPTX) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Leap Therapeutics ( (LPTX) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Leap Therapeutics ( (LPTX) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Leap Therapeutics ( (LPTX) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Leap Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Leap Therapeutics in short term and the sell signal is strong.
Leap Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Leap Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Leap Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.51 and Leap Therapeutics (LPTX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Leap Therapeutics (LPTX) stock. Volume based technical analysis of Leap Therapeutics (LPTX) stock is negative.
Leap Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.